ClinicalTrials.gg
Status unknownNCT02818127TCCT-TIMIUpdated Jul 12, 2016

Assessment Of Total Coronary Circulation Time Using TIMI Frame Count Method (TCCT-TIMI)

An interventional study of coronary angiography in Coronary Angiography, Coronary Artery Disease and Coronary Artery Ectasia, sponsored by Vascular and Molecular Cardiology Society. Status unknown at 3 sites in Turkey. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-07-12.

Sponsored by Vascular and Molecular Cardiology Society · Not applicable, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified Jul 2016), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
2,000
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The aim of this study is to evaluate and describe the total coronary circulation time (TCCT) by using TIMI frame count method in patients performed coronary angiography. TCCT is described as an angiographic index which is the sum of the frame count of coronary artery and venous system. This study also evaluates the relationship between the diseases in arterial system such as coronary artery ectasia, coronary slow flow, coronary artery disease and coronary venous pathologies.

02

Conditions studied

  • Coronary Angiography
  • Coronary Artery Disease
  • Coronary Artery Ectasia
  • Slow-Flow Phenomenon
  • Coronary Heart Disease
03

In context

Coronary Artery Disease

4,857 studies on the registry are indexed under Coronary Artery Disease; 890 are open to participants now.

This study's planned enrollment of 2,000 is above the median of 124 across 3,006 interventional studies indexed under Coronary Artery Disease.

Browse Coronary Artery Disease studies →

Lead sponsor

Vascular and Molecular Cardiology Society is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients whom performed coronary angiography with a suspicion of coronary artery disease

Exclusion criteria

Exclusion Criteria:

  • History of cerebrovascular disease, chronic inflamatuar disease, malignity, chronic kidney and hepatic disease
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Single group
Masking
Double (Investigator, Outcomes assessor)
Enrollment
2,000 participants (estimated)

Study arms

  • Active comparator
    normal coronary artery

    coronary angiography will be performed by transfemoral or transradial route.

    Procedure: coronary angiography

  • Active comparator
    coronary slow flow

    coronary angiography will be performed by transfemoral or transradial route.

    Procedure: coronary angiography

  • Active comparator
    coronary artery ectasia

    coronary angiography will be performed by transfemoral or transradial route.

    Procedure: coronary angiography

  • Active comparator
    non-obstructive coronary artery disease

    coronary angiography will be performed by transfemoral or transradial route.

    Procedure: coronary angiography

  • Active comparator
    obstructive coronary artery disease

    coronary angiography will be performed by transfemoral or transradial route.

    Procedure: coronary angiography

Interventions

  • Procedurecoronary angiography

    Coronary angiography will be performed by transfemoral or transradial approach in all patients. In order to evaluate each coronary artery, at least four views from the left and two views from the right system will be taken.

06

What researchers measure

Primary outcomes

  1. Evaluation of total coronary circulation time by using TIMI frame count method

    Time frame: 1 day

07

Study locations

3 of 3 sites recruiting
  • Gulhane Military Medical Academy
    Ankara, Kecioren, Turkey
    Recruiting
    • Turgay Celik, MD · Contactbenturgay@gmail.com · 905326731032
    • Turgay Celik, MD · Principal investigator
    • Mustafa Demir, MD · Sub investigator
    • Ali Osman Yıldırım, MD · Sub investigator
    • Cengiz Öztürk, MD · Sub investigator
  • Private Gozde Hospital
    Malatya, Turkey
    Recruiting
    • Izzet Tandogan, MD · Contact
    • Izzet Tandogan, MD · Principal investigator
  • Private Yenisehir Hospital
    Mersin, Turkey
    Recruiting
08

References and documents

Publications

  • von Ludinghausen M. The venous drainage of the human myocardium. Adv Anat Embryol Cell Biol. 2003;168:I-VIII, 1-104. doi: 10.1007/978-3-642-55623-4. PubMed 12645157 ↗
  • Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ, McCabe CH, Raymond L, Fortin T, Poole WK, Braunwald E. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation. 1996 Mar 1;93(5):879-88. doi: 10.1161/01.cir.93.5.879. PubMed 8598078 ↗

Individual participant data

Plan to share: Yes

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 12, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02818127
Lead sponsor
Vascular and Molecular Cardiology Society
Collaborators
Private Yenisehir Hospital, Private Gozde Hospital, Saglik Bilimleri Universitesi Gulhane Tip Fakultesi
Responsible party
Sponsor
First posted
Jun 29, 2016
Start date
Jul 2016
Primary completion
Jul 2017 (estimated)
Completion
Jul 2017 (estimated)
Last update
Jul 12, 2016

Study contacts

Ertan Yetkin, MD
Contact
ertanyetkin@hotmail.com
905327136721

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion